MLBON Stock Overview
Engages in the research, development, production, and distribution of oral and dental products in Belgium. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
bonyf N.V. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €16.70 |
| 52 Week High | €17.00 |
| 52 Week Low | €12.30 |
| Beta | 0 |
| 11 Month Change | -0.60% |
| 3 Month Change | 4.38% |
| 1 Year Change | 39.17% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 39.17% |
Recent News & Updates
Recent updates
Shareholder Returns
| MLBON | FR Specialty Retail | FR Market | |
|---|---|---|---|
| 7D | 6.4% | -2.2% | -0.3% |
| 1Y | 39.2% | -9.8% | -3.5% |
Return vs Industry: MLBON exceeded the French Specialty Retail industry which returned -8.8% over the past year.
Return vs Market: MLBON exceeded the French Market which returned -2.5% over the past year.
Price Volatility
| MLBON volatility | |
|---|---|
| MLBON Average Weekly Movement | 6.1% |
| Specialty Retail Industry Average Movement | 5.6% |
| Market Average Movement | 4.5% |
| 10% most volatile stocks in FR Market | 9.2% |
| 10% least volatile stocks in FR Market | 2.2% |
Stable Share Price: MLBON has not had significant price volatility in the past 3 months compared to the French market.
Volatility Over Time: MLBON's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1979 | n/a | Jean-Pierre Bogaert | www.bonyf.com |
bonyf N.V. engages in the research, development, production, and distribution of oral and dental products in Belgium. It offers PerioTabs, a brushing solution for gums, teeth, and dental implants to help reduce gingivitis, periodontitis, peri-mucositis, and peri-implantitis; and AphtoFix, a film-forming cream for the local treatment of mouth ulcers. The company also provides denture care products, such as OlivaFix denture adhesive creams and NitrAdine disinfecting denture tabs; Denture Repair-fix, an instant repair system for broken or cracked dentures and teeth detached from dentures; Fixobridge, a ready to use cement that fixes dislodged crowns, inlays, and bridges; denture relining cushion for ill-fitting dentures; Effervescent denture cleanser tabs; Superior denture adhesive creams; and Cavifix, a synthetic resin-based filling material to temporarily seal newly formed cavities and repair lost fillings or inlays.
bonyf N.V. Fundamentals Summary
| MLBON fundamental statistics | |
|---|---|
| Market cap | €9.83m |
| Earnings (TTM) | €0 |
| Revenue (TTM) | n/a |
n/a
P/E Ration/a
P/S RatioIs MLBON overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MLBON income statement (TTM) | |
|---|---|
| Revenue | €0 |
| Cost of Revenue | €0 |
| Gross Profit | €0 |
| Other Expenses | €0 |
| Earnings | €0 |
Last Reported Earnings
n/a
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did MLBON perform over the long term?
See historical performance and comparison